1. Circumstances, Postmortem Findings, Blood Concentrations and Metabolism in a Series of Methoxyacetylfentanyl-Related Deaths
- Author
-
Shimpei Watanabe, Henrik Gréen, Robert Kronstrand, Svante Vikingsson, and Anna Åstrand
- Subjects
Adult ,AcademicSubjects/SCI01040 ,Heart disease ,Health, Toxicology and Mutagenesis ,Urinary system ,AcademicSubjects/SCI00030 ,Physiology ,Pharmacology and Toxicology ,Urine ,Toxicology ,01 natural sciences ,Mass Spectrometry ,Analytical Chemistry ,Fentanyl ,03 medical and health sciences ,Humans ,Environmental Chemistry ,Medicine ,media_common.cataloged_instance ,European union ,030304 developmental biology ,media_common ,Cause of death ,0303 health sciences ,Chemical Health and Safety ,AcademicSubjects/MED00305 ,biology ,Special Issue ,business.industry ,010401 analytical chemistry ,Metabolism ,Farmakologi och toxikologi ,medicine.disease ,0104 chemical sciences ,Hepatocytes ,biology.protein ,Female ,Autopsy ,business ,Arylsulfatase ,Chromatography, Liquid ,medicine.drug - Abstract
Methoxyacetylfentanyl is one of many fentanyl analogs available as new psychoactive substances. It have been encountered in both the European Union and the United States, and existing literature suggest that methoxyacetylfentanyl is around 3- to 5-fold less potent than fentanyl. The aim of the present work was to combine case information with blood concentrations and abundance of urinary metabolites to investigate the importance of these parameters for toxicological interpretation. Quantification of methoxyacetylfentanyl in femoral blood was performed by LCMS-MS and urinary metabolites were analyzed by LC-QTOF-MS with and without hydrolysis with beta-glucuronidase/arylsulfatase. For confirmation of identified metabolites, methoxyacetylfentanyl was incubated with hepatocytes for up to 5 hours and analyzed with the same method as the urine samples. In eleven postmortem cases (27 to 41 years old and including one female) methoxyacetylfentanyl was reported in femoral blood. The cause of death was intoxication by methoxyacetylfentanyl alone or in combination with other drugs in all but one case, where death was attributed to acute complications of an underlying heart disease but with possible contribution from methoxyacetylfentanyl. In total, 27 urinary metabolites were found, including eight glucuronides. Major biotransformations were O-demethylation, dealkylation to form the nor-metabolite, monoand dihydroxylations of the phenethyl moiety, as well as combinations thereof. The most abundant metabolites in hydrolyzed urine included O-desmethyl-, O-desmethyl-phenethyl-hydroxy-, Odesmethyl-phenethyl-hydroxymethoxy- and nor-methoxyacetylfentanyl. Differences in the abundance of methoxyacetylfentanyl and its major metabolites could be interpreted to indicate fatal intoxications in abstinent or chronic users. We postulate that urinary concentrations of methoxyacetylfentanyl and two metabolites, in combination with the methoxyacetylfentanyl concentration in femoral blood, might be good indicators of the time between administration and death as well as prior use. Funding Agencies|Strategiomradet Forensiska Vetenskaper (Strategic Research Area Forensic Sciences) at Linkoping University, Sweden [2017-10]
- Published
- 2021
- Full Text
- View/download PDF